Published in Lab Business Week, September 11th, 2005
In addition, 600,000 shares were offered in a concurrent offering directly to a company shareholder in exchange for a $3 million reduction of a milestone payment obligation under the license agreement with the shareholder. Shares of Advanced Life Sciences common stock have been accepted to begin trading on the Nasdaq National Market under the trading symbol "ADLS."
Advanced Life Sciences has granted the underwriters a 30-day option to purchase up to 960,000 additional shares of common stock at the initial public...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.